Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial-Reference-Cited by-同舟云学术

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial

Published:2013-02 Issue:1 Volume:7 Page:34-43
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Louis Edouard,Löfberg Robert,Reinisch Walter,Camez Anne,Yang Mei,Pollack Paul F.,Chen Naijun,Chao Jingdong,Mulani Parvez M.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/7/1/34/1119505/7-1-34.pdf

Reference25 articles.

1. Management of Crohn's disease in adults;Lichtenstein;Am J Gastroenterol,2009

2. Unemployment and disability in patients with moderately to severely active Crohn's disease;Feagan;J Clin Gastroenterol,2005

3. Inflammatory bowel diseases: health care and costs in Sweden in 1994;Blomqvist;Scand J Gastroenterol,1997

4. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries;Lichtenstein;Am J Gastroenterol,2004

5. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systemic review;Loftus;Aliment Pharmacol Ther,2002

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis;Journal of Crohn's and Colitis;2024-04-22

2. Exploring work productivity loss in patients with inflammatory bowel disease;Future Science OA;2023-09

3. Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions;Inflammatory Bowel Diseases;2023-08-21

4. Methodological Issues Relevant to Blinding in Physical Medicine and Rehabilitation Research;American Journal of Physical Medicine & Rehabilitation;2023-03-03

5. The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease;Scientific Reports;2023-01-31